These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 37864626

  • 1. A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination.
    Masi S, Kobalava Z, Veronesi C, Giacomini E, Degli Esposti L, Tsioufis K.
    Adv Ther; 2024 Jan; 41(1):182-197. PubMed ID: 37864626
    [Abstract] [Full Text] [Related]

  • 2. Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy.
    Borghi C, Jayagopal PB, Konradi A, Bortolotto LA, Degli Esposti L, Perrone V, Snyman JR.
    Adv Ther; 2023 Apr; 40(4):1765-1772. PubMed ID: 36829102
    [Abstract] [Full Text] [Related]

  • 3. A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    Snyman JR, Bortolotto LA, Degli Esposti L, Jayagopal PB, Konradi AO, Perrone V, Borghi C.
    J Hypertens; 2024 Jan 01; 42(1):136-142. PubMed ID: 37728093
    [Abstract] [Full Text] [Related]

  • 4. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec 01; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and Tolerability of the Single-Pill Combination of Bisoprolol and Perindopril in Patients with Arterial Hypertension and Stable Coronary Artery Disease in Daily Clinical Practice: The STYLE Study.
    Boytsov SA, Burtsev YP, Khomitskaya YV, Karpov YA, STYLE study investigators.
    Adv Ther; 2021 Jun 01; 38(6):3299-3313. PubMed ID: 33991323
    [Abstract] [Full Text] [Related]

  • 6. Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
    Perrone V, Veronesi C, Gambera M, Nati G, Perone F, Tagliabue PF, Degli Esposti L, Volpe M.
    High Blood Press Cardiovasc Prev; 2019 Oct 01; 26(5):399-404. PubMed ID: 31463886
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective.
    Levy P, Lemański T, Crossan C, Lefebvre A, Brière JB, Degli Esposti L, Khan ZM.
    Expert Rev Pharmacoecon Outcomes Res; 2024 Oct 01; 24(8):967-975. PubMed ID: 38848115
    [Abstract] [Full Text] [Related]

  • 8. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Oct 01; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 9. Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy.
    Perez de Isla L, Liberopoulos E, Dovizio M, Veronesi C, Degli Esposti L, Zambon A.
    Adv Ther; 2024 Aug 01; 41(8):3407-3418. PubMed ID: 38963586
    [Abstract] [Full Text] [Related]

  • 10. A real-world analysis of adherence, biochemical outcomes, and healthcare costs in patients treated with rosuvastatin/ezetimibe as single-pill combination vs. free combination in Italy.
    Zambon A, Liberopoulos E, Dovizio M, Veronesi C, Degli Esposti L, Pérez de Isla L.
    Eur Heart J Open; 2024 Sep 01; 4(5):oeae074. PubMed ID: 39310723
    [Abstract] [Full Text] [Related]

  • 11. Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy.
    Rea F, Morabito G, Savaré L, Pathak A, Corrao G, Mancia G.
    J Hypertens; 2023 Sep 01; 41(9):1466-1473. PubMed ID: 37432906
    [Abstract] [Full Text] [Related]

  • 12. Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis.
    Kengne AP, Brière JB, Le Nouveau P, Kodjamanova P, Atanasov P, Kochoedo M, Irfan O, Khan ZM.
    Expert Rev Pharmacoecon Outcomes Res; 2024 Sep 01; 24(7):817-827. PubMed ID: 38088763
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study.
    Kobalava Z, Kvasnikov B, Burtsev Y, PRIDE study investigators.
    Adv Ther; 2023 Jun 01; 40(6):2725-2740. PubMed ID: 37029871
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study.
    Morabito G, Gregorio C, Ieva F, Barbati G, Mancia G, Corrao G, Rea F.
    BMC Public Health; 2024 Jul 06; 24(1):1808. PubMed ID: 38971775
    [Abstract] [Full Text] [Related]

  • 15. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B, Predel HG, Gillessen A, Hacke C, Vor dem Esche J, Rippin G, Noetel A, Randerath O.
    High Blood Press Cardiovasc Prev; 2020 Apr 06; 27(2):157-164. PubMed ID: 32219670
    [Abstract] [Full Text] [Related]

  • 16. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence.
    Sherrill B, Halpern M, Khan S, Zhang J, Panjabi S.
    J Clin Hypertens (Greenwich); 2011 Dec 06; 13(12):898-909. PubMed ID: 22142349
    [Abstract] [Full Text] [Related]

  • 17. Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study.
    Degli Esposti L, Perrone V, Veronesi C, Gambera M, Nati G, Perone F, Tagliabue PF, Buda S, Borghi C.
    Curr Med Res Opin; 2018 Sep 06; 34(9):1571-1577. PubMed ID: 29376432
    [Abstract] [Full Text] [Related]

  • 18. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
    Sung J, Ahn KT, Cho BR, Lee SY, Kim BJ, Kim DK, Park JI, Lee WS.
    Clin Transl Sci; 2021 May 06; 14(3):1185-1192. PubMed ID: 33503302
    [Abstract] [Full Text] [Related]

  • 19. Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis.
    Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J.
    Hypertension; 2021 Feb 06; 77(2):692-705. PubMed ID: 33390044
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension.
    Tsioufis K, Douma S, Kallistratos MS, Manolis AJ.
    Clin Drug Investig; 2019 Apr 06; 39(4):385-393. PubMed ID: 30790132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.